Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.
about
Revisiting the role of cladribine in acute myeloid leukemia: an improvement on past accomplishments or more old news?Cladribine in the treatment of chronic lymphocytic leukemia.2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia.A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors.Cladribine for untreated or early low-grade non-Hodgkin's lymphoma.An Escherichia coli system expressing human deoxyribonucleoside salvage enzymes for evaluation of potential antiproliferative nucleoside analogs.Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.Nucleoside analogues in the treatment of haematological malignancies.Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytesPharmacological basis for cladribine resistance.Cladribine for multiple sclerosis: review and current status.Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosineSynthesis of N(6) ,N(6)-Dialkyl Adenine Nucleosides With In Situ Formed Hexaalkylphosphorus TriamidesCladribine in indolent non-Hodgkin's lymphoma.The treatment of chronic progressive multiple sclerosis with cladribine.New treatment for acute myelogenous leukemia.Six-layer structure for genomics and its applications.Purine analogs in lymphoproliferative disorders.2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies.2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia.Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content.On the phosphorylation of 2-chlorodeoxyadenosine (CdA) and its correlation with clinical response in leukemia treatment.2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.The 2-chlorodeoxyadenosine-induced cell death signalling pathway in human thymocytes is different from that induced by 2-chloroadenosine.An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.Metabolism of the antineoplastic and immunosuppressive drug 2-CdA (Leustatin) in animals and humans.2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia.Development of cladribine treatment in multiple sclerosis.Drug Repurposing for the Treatment of Acute Myeloid Leukemia.Comparison of the in vitro and in vivo metabolism of Cladribine (Leustatin, Movectro) in animals and human.20th-century advances in drug therapy in oncology--Part I.
P2860
Q26860830-AB11115E-6284-4376-8B28-500EE7FFF248Q33337860-700969C2-1180-48DA-AD05-F73193AB2C5FQ33434186-784B8D65-22A7-45FD-9495-AD904712FC9CQ33490388-8F0E8387-F4AB-40C9-B626-307C768BE360Q33503391-4DD98A28-6054-4E1C-8FE4-3A98FBFE73C4Q33699299-CCC82ABD-4E89-4E51-83E2-DA66F801D943Q34263013-7F2D4C81-D009-4925-A2B7-B6AD2B58B90BQ34390281-9B239C89-D954-467C-810D-086F76C57469Q34529077-2CD3F52A-00C9-4475-AC8E-CF1336BC12AEQ35614649-D7A7A451-8C44-49A9-B7A0-6E2DAA2459DDQ36307847-73025D56-573D-488D-82BD-55561C904128Q36931065-686FD52B-6036-4C15-9F46-8522D0EA3BBCQ37074812-E3B19ADC-8526-41BF-81B8-3B810EEBB751Q37134422-AD491691-1261-45AD-A274-132260D45ABCQ37725229-DB238D1B-D013-4D3C-8858-D5E89C0ECCF8Q38284045-7DADAD8D-84E9-492E-9942-5425C5A295BCQ40331497-C1060AE3-DEA7-4756-B590-C0374F856C81Q40621426-CBE525CC-9B6A-48E4-9AEA-22B4C4819140Q40709682-02A8AE60-8DAD-46C6-BE46-78D7D443E43DQ40713180-FDB91FE5-AC68-4C77-BBD2-B3D782B9ECA1Q40750589-17F91056-7198-48D3-B12E-478EA297FF07Q41049811-857A4029-0CC5-4F76-B1D9-2A5B0F72105CQ42390436-98BC5CED-E463-476C-9B7E-D810C3644472Q42822234-227C0913-8660-4718-BBC4-25C9B2CA970EQ44960566-8AFED531-449E-4E79-BCD6-81542E022F7DQ44995254-B4135F4B-36FC-4B7F-B500-D47D83456B27Q46122059-4CA15110-29AF-4259-8396-70EEEAF9D6CDQ46134457-2EA85B9D-60D9-408D-9350-06BCA2FD6014Q46520922-7DE2A823-7E81-4C55-8AC3-4D60775F5DC2Q47094576-3F837A0D-1D05-4C65-A575-A1C6CD8E3E62Q53109464-2E4592E6-E7BC-43AB-8B50-8E984C36BA60Q53513591-4CF0EDC5-9ED6-4040-9B5F-0C55B995127A
P2860
Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.
@ast
Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.
@en
type
label
Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.
@ast
Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.
@en
prefLabel
Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.
@ast
Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.
@en
P2093
P2860
P356
P1476
Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.
@en
P2093
P2860
P304
P356
10.1073/PNAS.81.7.2232
P407
P577
1984-04-01T00:00:00Z